Complexity and clinical significance of drug–drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer-associated thrombosis (CAT)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-7339
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Complexity and clinical significance of drug–drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer-associated thrombosis (CAT) ; volume:30 ; number:10 ; day:6 ; month:8 ; year:2022 ; pages:8559-8573 ; date:10.2022
Supportive care in cancer ; 30, Heft 10 (6.8.2022), 8559-8573, 10.2022
- Urheber
-
Tsoukalas, Nikolaos
Brito-Dellan, Norman
Font, Carme
Butler, Taylor
Rojas-Hernandez, Cristhiam M.
Butler, Thomas
Escalante, Carmen
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00520-022-07235-8
- URN
-
urn:nbn:de:101:1-2022121421155492061894
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tsoukalas, Nikolaos
- Brito-Dellan, Norman
- Font, Carme
- Butler, Taylor
- Rojas-Hernandez, Cristhiam M.
- Butler, Thomas
- Escalante, Carmen
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction to: Complexity and clinical significance of drug–drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer‑associated thrombosis (CAT)
Anti-coagulant Treatment of Cancer-Associated Thrombosis in Frail Patients: Impact of Frailties on the Management of Drug–Drug Interactions
Challenging Situations in the Treatment of Cancer-Associated Thrombosis
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Lurasidone drug-drug interaction studies: a comprehensive review
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Case report: Medical cannabis—warfarin drug-drug interaction
DPDDI: a deep predictor for drug-drug interactions
Evaluating drug-drug interaction information in NDF-RT and DrugBank
Correction to: Complexity and clinical significance of drug–drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer‑associated thrombosis (CAT)
Anti-coagulant Treatment of Cancer-Associated Thrombosis in Frail Patients: Impact of Frailties on the Management of Drug–Drug Interactions
Challenging Situations in the Treatment of Cancer-Associated Thrombosis
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Lurasidone drug-drug interaction studies: a comprehensive review
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Case report: Medical cannabis—warfarin drug-drug interaction
DPDDI: a deep predictor for drug-drug interactions
Evaluating drug-drug interaction information in NDF-RT and DrugBank
Correction to: Complexity and clinical significance of drug–drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer‑associated thrombosis (CAT)
Anti-coagulant Treatment of Cancer-Associated Thrombosis in Frail Patients: Impact of Frailties on the Management of Drug–Drug Interactions
Challenging Situations in the Treatment of Cancer-Associated Thrombosis
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Lurasidone drug-drug interaction studies: a comprehensive review
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Case report: Medical cannabis—warfarin drug-drug interaction
DPDDI: a deep predictor for drug-drug interactions